Nejat Dalay

3.8k total citations
116 papers, 3.1k citations indexed

About

Nejat Dalay is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Nejat Dalay has authored 116 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 43 papers in Cancer Research and 41 papers in Oncology. Recurrent topics in Nejat Dalay's work include Genetic factors in colorectal cancer (21 papers), Epigenetics and DNA Methylation (20 papers) and Cancer Genomics and Diagnostics (17 papers). Nejat Dalay is often cited by papers focused on Genetic factors in colorectal cancer (21 papers), Epigenetics and DNA Methylation (20 papers) and Cancer Genomics and Diagnostics (17 papers). Nejat Dalay collaborates with scholars based in Türkiye, United States and Germany. Nejat Dalay's co-authors include Uğur Gezer, Mustafa Işın, Nur Buyru, Emre Özgür, Semra Demokan, Hülya Yazıcı, Stefan Holdenrieder, Nilgün Erten, Yavuz Dizdar and Emin Darendeliler and has published in prestigious journals such as PLoS ONE, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Nejat Dalay

115 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nejat Dalay Türkiye 31 2.2k 1.6k 790 408 313 116 3.1k
Jeffrey S. Humphrey United States 24 1.1k 0.5× 781 0.5× 594 0.8× 167 0.4× 312 1.0× 35 2.4k
Marı́a José Calasanz Spain 43 3.0k 1.4× 1.1k 0.7× 866 1.1× 774 1.9× 501 1.6× 153 5.1k
Avaniyapuram Kannan Murugan Saudi Arabia 31 1.8k 0.8× 797 0.5× 894 1.1× 402 1.0× 527 1.7× 63 3.6k
María Aparecida Nagai Brazil 27 1.6k 0.7× 417 0.3× 619 0.8× 301 0.7× 261 0.8× 113 2.5k
Ludwig Wilkens Germany 27 1.2k 0.5× 495 0.3× 575 0.7× 261 0.6× 278 0.9× 77 2.5k
Ian Tomlinson United Kingdom 30 1.4k 0.7× 918 0.6× 1.2k 1.5× 1.6k 3.9× 502 1.6× 48 3.2k
Takako Kawasaki United States 27 1.9k 0.9× 988 0.6× 1.6k 2.0× 1.4k 3.5× 196 0.6× 29 3.3k
Takashi Sakatani Japan 20 1.0k 0.5× 445 0.3× 707 0.9× 268 0.7× 231 0.7× 72 1.9k
Hiroaki Ueo Japan 31 1.2k 0.5× 839 0.5× 1.0k 1.3× 351 0.9× 203 0.6× 133 2.9k
Hui‐Zi Chen United States 12 1.4k 0.6× 774 0.5× 1.1k 1.4× 404 1.0× 94 0.3× 25 2.6k

Countries citing papers authored by Nejat Dalay

Since Specialization
Citations

This map shows the geographic impact of Nejat Dalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nejat Dalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nejat Dalay more than expected).

Fields of papers citing papers by Nejat Dalay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nejat Dalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nejat Dalay. The network helps show where Nejat Dalay may publish in the future.

Co-authorship network of co-authors of Nejat Dalay

This figure shows the co-authorship network connecting the top 25 collaborators of Nejat Dalay. A scholar is included among the top collaborators of Nejat Dalay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nejat Dalay. Nejat Dalay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baykara, Onur, et al.. (2017). The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis. International Journal of Medical Sciences. 14(7). 675–679. 13 indexed citations
2.
Dalay, Nejat. (2016). Role of the lncRNAs in malignant melanoma and their involvement in metastasis. Translational Cancer Research. 5(4). 2 indexed citations
3.
Gezer, Uğur, et al.. (2015). Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer. Molecular and Clinical Oncology. 3(4). 954–958. 14 indexed citations
4.
Baykara, Onur, et al.. (2015). Amplification of Chromosome 8 Genes in Lung Cancer. Journal of Cancer. 6(3). 270–275. 33 indexed citations
5.
Işın, Mustafa, et al.. (2015). Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Frontiers in Genetics. 6. 168–168. 186 indexed citations
6.
Gezer, Uğur, Serkan Keskın, Abdullah İğci, et al.. (2014). Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy. Oncology Letters. 8(2). 845–848. 20 indexed citations
7.
Işın, Mustafa, Mustafa Nuri Yenerel, Melih Aktan, Nur Buyru, & Nejat Dalay. (2011). Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia. DNA and Cell Biology. 31(5). 777–782. 5 indexed citations
8.
Demokan, Semra, et al.. (2010). Simultaneous Methylation Profiling of Tumor Suppressor Genes in Head and Neck Cancer. DNA and Cell Biology. 30(1). 17–24. 14 indexed citations
9.
Demokan, Semra, Yusufhan Süoğlu, Murat Ulusan, & Nejat Dalay. (2010). Analysis of the hMSH2 Gene Variants in Head and Neck Cancer. DNA and Cell Biology. 29(8). 449–457. 2 indexed citations
10.
Buyru, Nur, et al.. (2009). Methylation Profiles in Breast Cancer. Cancer Investigation. 27(3). 307–312. 25 indexed citations
11.
Gezer, Uğur, et al.. (2008). Effect of Adjuvant Chemotherapy on Integrity of Free Serum DNA in Patients with Breast Cancer. Annals of the New York Academy of Sciences. 1137(1). 175–179. 24 indexed citations
12.
Dalay, Nejat, et al.. (2007). Functional polymorphism of thymidylate synthase, but not of the COMT and IL‐1B genes, is associated with breast cancer. Journal of Clinical Laboratory Analysis. 21(2). 97–102. 21 indexed citations
13.
Oğuz, Hilal, Hakan Çamlıca, Derya Duranyıldız, et al.. (2006). Matriks metalloproteinazlar ve akciğer kanseri. DergiPark (Istanbul University). 21(2). 53–56. 3 indexed citations
14.
Gezer, Uğur, et al.. (2005). Methylation of the INK4A/ARF locus in blood mononuclear cells. Annals of Hematology. 85(2). 102–107. 11 indexed citations
15.
Buyru, Nur, et al.. (2005). Molecular Analysis of the P27/Kip1 Gene in Breast Cancer. Molecular Diagnosis. 9(1). 17–21. 10 indexed citations
16.
Dalay, Nejat, et al.. (2004). Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk. Experimental and Molecular Pathology. 76(3). 260–263. 36 indexed citations
17.
Yazıcı, Hülya, et al.. (2003). Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.. PubMed. 113-114. 307–14. 18 indexed citations
18.
Gezer, Uğur, et al.. (2003). Genotyping of the MTHFR Gene Polymorphism, C677T in Patients with Leukemia by Melting Curve Analysis. Molecular Diagnosis. 7(3). 181–185. 27 indexed citations
19.
Yazıcı, Hülya, Musa Altun, Günter Hafız, & Nejat Dalay. (2001). Serum and Tissue c-erb B2, bcl-2, and Mutant p53 Oncoprotein Levels in Nasopharyngeal Cancer. Cancer Investigation. 19(8). 773–778. 1 indexed citations
20.
Yazıcı, Hülya, et al.. (1999). Bcl-2 gene rearrangements and apoptosis rates in patients with Non-Hodgkin’s lymphoma during chemotherapy. Clinical Biochemistry. 32(1). 45–49. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026